CIFR vs. MLTX
CIFR (Cipher Digital Inc.) and MLTX (MoonLake Immunotherapeutics) are both stocks. CIFR operates in Information Technology Services (Technology), while MLTX operates in Biotechnology (Healthcare). Over the past 3 years, CIFR returned 113.71%/yr vs -10.04%/yr for MLTX. At a 0.15 correlation, their price movements are largely independent.
Performance
CIFR vs. MLTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CIFR achieves a 65.99% return, which is significantly higher than MLTX's 41.81% return.
CIFR
- 1D
- 8.26%
- 1M
- 15.35%
- YTD
- 65.99%
- 6M
- 43.70%
- 1Y
- 538.02%
- 3Y*
- 113.71%
- 5Y*
- —
- 10Y*
- —
MLTX
- 1D
- 5.30%
- 1M
- 1.52%
- YTD
- 41.81%
- 6M
- 26.37%
- 1Y
- -57.54%
- 3Y*
- -10.04%
- 5Y*
- 13.19%
- 10Y*
- —
CIFR vs. MLTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CIFR Cipher Digital Inc. | 65.99% | 218.10% | 12.35% | 637.50% | -87.90% | -54.65% |
MLTX MoonLake Immunotherapeutics | 41.81% | -75.66% | -10.33% | 475.14% | 6.17% | 0.41% |
Correlation
The correlation between CIFR and MLTX is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Aug 30, 2021 | 0.15 |
Fundamentals
CIFR:
$9.93B
MLTX:
$1.33B
CIFR:
-$2.33
MLTX:
-$3.90
CIFR:
13.90
MLTX:
5.24
CIFR:
$174.98M
MLTX:
$0.00
CIFR:
-$172.84M
MLTX:
-$1.49M
CIFR:
-$169.22M
MLTX:
-$179.84M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CIFR vs. MLTX — Risk / Return Rank
CIFR
MLTX
CIFR vs. MLTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cipher Digital Inc. (CIFR) and MoonLake Immunotherapeutics (MLTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CIFR | MLTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +5.47 | ||
| Sortino ratioReturn per unit of downside risk | +3.04 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 1.20 | +0.25 |
| Calmar ratioReturn relative to maximum drawdown | 10.56 | -0.64 | +11.21 |
| Martin ratioReturn relative to average drawdown | 21.19 | -0.90 | +22.09 |
Loading charts...
Drawdowns
CIFR vs. MLTX - Drawdown Comparison
The maximum CIFR drawdown since its inception was -97.16%, which is greater than MLTX's maximum drawdown of -90.22%. Use the drawdown chart below to compare losses from any high point for CIFR and MLTX.
Loading charts...
Drawdown Indicators
| CIFR | MLTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.16% | -90.22% | -6.94% |
Max Drawdown (1Y)Largest decline over 1 year | -51.38% | -89.93% | +38.55% |
Max Drawdown (3Y)Largest decline over 3 years | -71.74% | -90.22% | +18.48% |
Max Drawdown (5Y)Largest decline over 5 years | — | -90.22% | — |
Current DrawdownCurrent decline from peak | -6.81% | -70.73% | +63.92% |
Average DrawdownAverage peak-to-trough decline | -66.24% | -29.34% | -36.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.57% | 63.83% | -38.26% |
Volatility
CIFR vs. MLTX - Volatility Comparison
Cipher Digital Inc. (CIFR) has a higher volatility of 31.19% compared to MoonLake Immunotherapeutics (MLTX) at 16.28%. This indicates that CIFR's price experiences larger fluctuations and is considered to be riskier than MLTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CIFR | MLTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 31.19% | 16.28% | +14.91% |
Volatility (6M)Calculated over the trailing 6-month period | 72.25% | 55.39% | +16.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 109.30% | 115.66% | -6.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 121.97% | 91.15% | +30.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 121.97% | 86.34% | +35.63% |
Dividends
CIFR vs. MLTX - Dividend Comparison
Neither CIFR nor MLTX has paid dividends to shareholders.
Financials
CIFR vs. MLTX - Financials Comparison
This section allows you to compare key financial metrics between Cipher Digital Inc. and MoonLake Immunotherapeutics. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CIFR and MLTX have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CIFR has higher volatility (31.19%) compared to MLTX (16.28%). In terms of maximum drawdown, CIFR dropped -97.16% vs MLTX's -90.22%.
CIFR currently has the higher Sharpe Ratio (4.98 vs -0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CIFR and MLTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer